Kagan and Soai Win 2026 Nobel Chemistry Prize for Work on Mirror-Image Molecules

The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan and Kenso Soai for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. The work addresses a long-standing question of how living systems came to use only one of two possible mirror-image forms of certain molecules.

Many molecules exist as pairs of structures that are mirror images of each other, a property known as chirality. Amino acids and other building blocks of life appear in nature in only one of the two forms. How that preference emerged spontaneously was unresolved for more than a century. Kagan and Soai developed reactions in which a small initial imbalance is amplified, allowing chemists to produce predominantly one mirror image.

Kagan, 95, is professor emeritus at Université Paris-Sud in France. He has studied chirality since the 1960s. When other researchers received the 2001 Chemistry Nobel for related asymmetric catalysis, some French scientists noted that Kagan’s earlier contributions had been overlooked. Soai, 76, is professor emeritus at Tokyo University of Science. He received the news while grocery shopping and later said sharing the prize with Kagan was the most exciting day of his life.

The committee described their discoveries as decisive for chemists who design reactions used in pharmaceutical manufacture. Many drugs must be produced as a single mirror-image form because the opposite form can be inactive or harmful. The thalidomide tragedy illustrated the risk when both forms are present. The reactions developed by Kagan and Soai provide practical routes to the desired form.

Soai’s best-known experiment, the Soai reaction, demonstrated autocatalysis in which the product of a reaction catalyses its own formation and amplifies a tiny excess of one mirror image. The result was the first laboratory demonstration of the spontaneous emergence of homochirality from achiral starting materials under conditions relevant to organic chemistry. Kagan’s earlier observations of non-linear effects supplied part of the theoretical foundation.

Heiner Linke, chair of the Nobel Committee for Chemistry, said the pair had solved a chemical mystery more than a century old. The prize amount of 12 million Swedish kronor will be shared equally. The award was announced on 7 October in Stockholm, the third science prize of the week after medicine and physics.

Kagan’s research in the 1970s and 1980s mapped how small differences in catalyst composition could produce large differences in the ratio of mirror-image products. Those non-linear effects contradicted the simple expectation that product ratios would mirror catalyst ratios. The findings guided later catalyst design.

Soai extended the work into self-replicating systems. In the Soai reaction an organozinc compound adds to an aldehyde; the resulting alcohol then accelerates the formation of more of the same mirror-image alcohol. Starting with a barely detectable excess, the reaction can yield material that is almost entirely one form. The experiment has been repeated and refined by other laboratories.

Pharmaceutical companies already use asymmetric catalysis on industrial scale. The Nobel recognition highlights the fundamental insight that made many of those processes possible and that continues to inform the search for new catalysts. Safer and more efficient routes to single-enantiomer drugs reduce both cost and the risk of adverse effects from the unwanted mirror image.

The origins-of-life implication remains partly open. The laboratory reactions show that homochirality can arise without biological machinery, but they do not prove that the same pathway operated on the early Earth. Researchers continue to test whether similar amplification could have occurred under prebiotic conditions.

Kagan was born in 1930 and has remained active in advisory roles. Soai was born in Hiroshima in 1950 and completed his doctorate at the University of Tokyo in 1979. Both have published extensively; their key papers from the 1980s and 1990s are now standard references in stereochemistry.

The 2026 Chemistry Nobel follows the medicine prize for optogenetics and the physics prize for neutrino astronomy. The literature prize went to Anne Carson and the peace prize to Navi Pillay. The chemistry award continues the Academy’s practice of recognising work that combines deep conceptual insight with practical consequences for industry.

At the Tokyo press conference Soai said he intended to continue contributing to the field. Kagan has not made extensive public remarks since the announcement. Colleagues in France described the recognition as overdue. The shared prize acknowledges complementary contributions separated by roughly two decades.

Mirror-image molecules remain a central concern in drug regulation. Regulatory agencies require manufacturers to characterise and control the enantiomeric composition of active ingredients. The synthetic methods recognised by the Nobel Committee are among the tools used to meet those requirements.

The discovery also supplies a concrete chemical model for discussions of biological asymmetry. Textbooks now include the Soai reaction alongside Pasteur’s nineteenth-century separation of tartaric-acid crystals as landmark observations. The Nobel citation places both the non-linear effects and the autocatalytic amplification in a single narrative.

Industrial adoption has been gradual. Early asymmetric hydrogenations and the later self-amplifying systems required specialised conditions. Subsequent catalyst improvements have broadened the range of substrates that can be processed at scale. The prize is expected to draw additional research funding to related catalytic systems.

The announcement was made at the Royal Swedish Academy of Sciences. Live video showed the committee members and later included a telephone connection to Soai. Kagan was not reached for an immediate on-camera reaction. Formal ceremonies will take place in Stockholm in December.

The work of Kagan and Soai demonstrates that a small chemical bias can be turned into a large practical advantage. That principle now underpins a substantial fraction of modern pharmaceutical synthesis and continues to shape experiments aimed at understanding how life’s molecular handedness first appeared.